Vikas Lifecare per share figures

Share price at each year-end
Tap a line for its trendCurrentlast closeFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹0.10₹0.10−₹0.04₹0.09−₹0.11
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹0.10₹0.10−₹0.04₹0.08−₹0.11
₹2.97₹2.97₹2.86₹2.88₹2.30
₹2.68₹2.68₹2.58₹2.70₹3.31
₹1.66₹1.66−₹1.19−₹0.25−₹0.77
₹1.66₹1.66−₹1.19−₹0.35−₹0.89
186.0186.0186.0165.2143.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIKASLIFE₹1.12

Vikas Lifecare Limited

· Consumer Services
₹ CrorePeersSAKUMAESSENTIAKOTHARIPROANIKINDSOSWALAGROLANDSMILLGOYALALUMSTCINDIAMcap ₹208 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current
last close
Basic EPS-0.110.09-0.040.100.10
Diluted EPS-0.110.08-0.040.100.10
Book Value per Share2.302.882.862.972.97
Revenue per Share3.312.702.582.682.68
Cash Flow per Share-0.77-0.25-1.191.661.66
Free Cash Flow per Share-0.89-0.35-1.191.661.66
Shares Outstanding (cr)143.9165.2186.0186.0186.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.